Vantage Hemp Co. Sub
Vantage Hemp Co. Submits Drug Master File for CBD Isolate to the U.S. Food & Drug Administration
April 04, 2023 07:00 ET | Vantage Hemp
Greeley, Colorado, April 04, 2023 (GLOBE NEWSWIRE) -- Vantage Hemp Co. (“Vantage” or the “Company”) announces that it has submitted a Drug Master File (DMF) for its cannabidiol (CBD) Isolate to the...
22nd Century Group logo.jpg
22nd Century Group (XXII) Announces Filing of U.S. DMF (Drug Master File) for CBD API; New Global Sales, Marketing and Distribution Agreement with Transo-Pharm for Cannabinoid APIs
January 23, 2023 09:20 ET | 22nd Century Group, Inc
BUFFALO, N.Y., Jan. 23, 2023 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), a leading biotechnology company dedicated to improving health with reduced nicotine tobacco, hemp/cannabis...
ExCellThera announce
ExCellThera announces submission of Drug Master File for UM171
June 17, 2022 08:05 ET | ExCellThera
MONTRÉAL, June 17, 2022 (GLOBE NEWSWIRE) -- ExCellThera Inc. (ExCellThera), an advanced clinical-stage biotechnology company delivering molecules and bioengineering solutions to expand and...
InterpaceBiosciences_New Logo.png
Miroculus to Optimize Automated Next Generation Sequencing Library Preparation with Interpace Diagnostics and Twist Bioscience
May 11, 2022 08:30 ET | Interpace Biosciences, Inc.
PARSIPPANY, NJ, May 11, 2022 (GLOBE NEWSWIRE) -- Interpace Biosciences, Inc. (OTCQX: IDXG) (“Interpace” or the “Company”), a leader in enabling personalized medicine, has announced that in...
Global Dimethylformamide Market Report 2021-2027: Analysis & Forecast by Applications (Catalyst, Reactant, Feedstock), End-Users (Agrochemical, Electronics, Chemical & Petrochemical, Pharmaceutical)
November 01, 2021 07:48 ET | Research and Markets
Dublin, Nov. 01, 2021 (GLOBE NEWSWIRE) -- The "Dimethylformamide Market - Global Forecast up to 2027" report has been added to's offering. The Dimethylformamide Market is...